This article was updated and reposted October 31, 2011 with new information. Access the updated article by clicking HERE.
People across the country are starting to ask “What happened to Tri-luma?”. Without any formal announcement from its maker (Galderma), supplies of the product just started to dry up. It’s no longer at the pharmacies, and the few physicians offices that stocked and dispensed it directly seem to be out as well. The reason why is apparently something that Galderma has not been quick to comment on. One of the very few references to it anywhere comes from a dermatologist who was quoted in late October 2010 on the ELLE magazine website as saying “Tri-Luma is on back-order right now, which is very rare for a prescription product.”
However we did find a posting on the FDA’s website for recall advisories confirming that Galderma actually issued a full recall in late August, 2010 of all Tri-Luma product manufactured by its sub-contract manufacturer, Hill Dermaceuticals. The reason given for the recall was that Hill notified Galderma of “a subpotent active ingredient.” This reason seems to indicate that they discovered one of the active ingredients in Tri-Luma (the main actives are Hydroquinone, Tretinoin, and the corticosteroid fluocinolone acetonide), was not meeting labeling standards of concentration and/or potency.
There is no word as to when Tri-luma may be re-introduced to the market. However, with every challenge there is opportunity, and this may be an opportunity for those Tri-luma patients to try something else to address their skin tone concerns. Even when it was available, Tri-Luma use is generally limited to a few weeks at a time, and the question is, what will you use after that? In fact, the FDA issued a warning on Tri-Luma last year as well – requiring clear instructions that “Tri-Luma is indicated for the short term treatment” and NOT for ongoing maintenance of melasma. And yet, patients who don’t use anything after their initial Tri-Luma treatment often suffer a “rebounding” effect where their melasma comes back – potentially worse than it was before. Since entering the market earlier this year, Lumixyl has provided the answer.
While not a drug, the Lumixyl Topical Brightening System is the obvious alternative for those looking for brighter, clearer, healthier skin and a more even tone. In fact, one of its strengths is that it does not rely on topical steroids, hydroquinone, or other harsh and irritating drugs to promote healthy skin tone. Instead, it relies on a decapeptide-12, a non-toxic, non-irritating peptide proven to reduce the appearance of hyperpigmentation for a more even complexion. The system also incorporates powerful antioxidants and clinical grade glycolic acid to stimulate cell turnover, aid collagen and fibroblast proliferation, and prevent photo-damage from occurring, resulting in improved skin texture and quality.
Four Steps to a Brighter You
The Lumixyl Topical Brightening System is an entirely new approach to naturally brighter, more vibrant skin, representing a new standard in physician-grade skincare.
An innovation in skin brightening technology, the four products that comprise the Lumixyl Topical Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence.
Through the use of botanical antioxidants, the Active-Prep Cleanser contributes to lower levels of oxidative stress in the skin for reduced melanin stimulation, while the Lumixyl peptide – Decapeptide-12 – in the Lumixyl Topical Brightening Creme, works to help regulate overproduction of melanin by inhibiting the tyrosinase enzyme used to create melanin by the melanocytes in your skin.
The GlycoPeel 20 Rapid Exfoliating Lotion uses a clinical grade glycolic acid to help remove the dead layers of the stratum corneum, where hyperpigmented cells can concentrate. This level of exfoliation also helps healthy skin function by stimulating the skin’s natural turnover process.
The MoistureLock Sunscreen SPF30 is a breakthrough in elegant sun protection. This sunscreen helps to prevent UV-induced melanin overproduction, and protects the skin from photo-damage that leads to prematurely aged skin.
A clinical study published in the Journal of Drugs in Dermatology was conducted with 5 patients who had used Tri-Luma previously without achieving successful clearance of their melasma (skin discoloration), showed that in every case they achieved significant clearance of the melasma after 12 weeks of daily application of the Lumixyl peptide.
If you are looking for a solution for skin discoloration and were frustrated to find that Tri-Luma is not available, Lumixyl may actually be the real solution you are looking for.
Related Articles: Breaking News – Hydroquinone Banned In Texas?